According to Biolife Solutions 's latest financial reports the company's current EPS (TTM) is -1,87 โฌ. In 2022 the company made an earnings per share (EPS) of -3,19 โฌ a decrease over its 2021 EPS that were of -0,19 โฌ.
Year | EPS | Change |
---|---|---|
2023 (TTM) | -1,81 โฌ | -43.14% |
2022 | -3,19 โฌ | 1555.58% |
2021 | -0,19 โฌ | -383.03% |
2020 | 0,06798 โฌ | -117.07% |
2019 | -0,40 โฌ | -327.78% |
2018 | 0,17 โฌ | -185.71% |
2017 | -0,20 โฌ | -61.82% |
2016 | -0,53 โฌ | 57.14% |
2015 | -0,34 โฌ | 9.38% |
2014 | -0,31 โฌ | 44.51% |
2013 | -0,22 โฌ | -43.17% |
2012 | -0,38 โฌ | -30.42% |
2011 | -0,54 โฌ | -0% |
2010 | -0,54 โฌ | -0% |
2009 | -0,54 โฌ | -0% |
2008 | -0,54 โฌ | -0% |
2007 | -0,54 โฌ | -0% |
2006 | -0,54 โฌ | -0% |
2005 | -0,54 โฌ | -33.33% |
2004 | -0,82 โฌ | -62.5% |
2003 | -2,18 โฌ | -500% |
2002 | 0,54 โฌ | -110.81% |
2001 | -5,03 โฌ | 45.36% |
2000 | -3,46 โฌ | |
1998 | -0,45 โฌ | -20.37% |
1997 | -0,56 โฌ |